RecruitingNCT05645055
Biologics for Stricturing Crohn's Diseases
The Clinical Outcomes of Patients With Stricturing Crohn's Diseases Received Biologics: a Prospective, Observative Study
Sponsor
Jinling Hospital, China
Enrollment
200 participants
Start Date
Jan 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.
Eligibility
Min Age: 16 YearsMax Age: 65 Years
Inclusion Criteria4
- patients with stricturing Crohn's diseases
- no surgical indication
- patients with asymptomatic penetrating diseases
- written consent acquired
Exclusion Criteria4
- patients with surgical indication
- patients with symptomatic penetrating diseases
- contraindication of biologics
- anticipating other trial
Interventions
OTHERtreat these patients with biologics
treat these patients with biologics
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05645055